Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

LAKAN INJECTION 1% - HSA Drug Approval Details

Approvals/HSA/LAKAN INJECTION 1%

Approved

THERAPEUTIC

LAKAN INJECTION 1%

DUOPHARMA (M) SDN BHD (MALAYSIA)🇸🇬 Health Sciences Authority

Approval Date: Jul 22, 1999
Approval ID: b49d98873e6c6b60
Company: DUOPHARMA (M) SDN BHD (MALAYSIA)
Type: Therapeutic

Approval Details

Approval Id: b49d98873e6c6b60
Drug Name: LAKAN INJECTION 1%
Product Name: LAKAN INJECTION 1%
Approval Number: SIN11040P
Approval Date: 1999-07-22
Registrant: DUOPHARMA (SINGAPORE) PTE LTD
Licence Holder: DUOPHARMA (SINGAPORE) PTE LTD
Drug Type: Therapeutic
Forensic Classification: PRESCRIPTION ONLY MEDICINES
Dosage Form: INJECTION
Route Of Administration: SUBCUTANEOUS
Atc Code: N01BB02
Atc Item Name: lidocaine
Pharma Manufacturer Name: DUOPHARMA (SINGAPORE) PTE. LTD.
Company Detail Path: /organization/duopharma-singapore-pte-ltd

Active Ingredients

LIGNOCAINE HCl

1%

LIGNOCAINE HCL

1%

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Jul 22, 1999

Approval ID

b49d98873e6c6b60

Type

Therapeutic

Back to HSA Approvals